pandem
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
becom
global
threat
public
health
singlestrand
rna
viru
sequenc
ident
bat
coronaviru
spike
protein
respons
entri
host
cell
via
bind
surfac
angiotensin
convert
enzym
estim
mortal
rate
rang
day
onset
symptom
death
promin
patholog
chang
lung
includ
edema
proteinac
exud
multinucl
pneumocyt
first
report
lipid
pathophysiolog
perform
retrospect
longitudin
analysi
patient
n
admit
januari
februari
depart
infecti
diseas
zhongnan
hospit
wuhan
univers
wuhan
china
studi
approv
institut
review
board
hospit
patient
routin
laboratori
test
includ
lipid
hospit
januari
prior
infect
test
posit
epidem
includ
studi
patient
admit
hospit
januari
februari
either
discharg
die
march
healthi
subject
n
patient
chronic
obstruct
pulmonari
diseas
copd
n
lipid
test
hospit
septemb
octob
includ
normal
control
electron
medic
record
includ
demograph
clinic
treatment
laboratori
data
extract
abbrevi
alp
alkalin
phosphatas
alt
alanin
aminotransferas
ast
aspart
aminotransferas
coronaviru
diseas
crp
creactiv
protein
hscrp
highsensit
creactiv
protein
ggt
gammaglutamyl
transferas
hdl
highdens
lipoprotein
sever
acut
respiratori
syndrom
coronaviru
tc
total
cholesterol
page
detail
method
describ
supplementari
materi
data
present
median
interquartil
rang
iqr
mean
standard
deviat
sd
mannwhitney
u
test
use
compar
differ
group
averag
age
patient
year
male
femal
morbid
diabet
hypertens
cardiovascular
disord
hyperlipidemia
kidney
diseas
onset
symptom
patient
fever
cough
fatigu
short
breath
diarrhea
tabl
sever
admit
patient
mild
sever
critic
classif
accord
chines
center
diseas
control
cdc
guidelin
patient
receiv
standard
treatment
base
guidelin
chines
cdc
includ
antivir
remedi
arbidol
lopinavir
ribonavir
interferon
inhal
antiinflammatori
treatment
corticosteroid
immunemodul
thymalfasin
immunoglobulin
tabl
sever
critic
case
given
highflow
oxygen
noninvas
invas
ventil
depend
morbid
seventeen
patient
recov
discharg
four
patient
surviv
stage
diseas
progress
significantli
higher
level
creactiv
protein
crp
versu
mgl
p
versu
tabl
tabl
patient
surviv
continu
increas
hscrp
level
lymphopenia
death
supplementari
tabl
next
analyz
serum
lipid
level
mmoll
patient
infect
entir
cours
diseas
averag
timelin
diseas
cours
shown
fig
tabl
ldl
hdl
tc
level
patient
surviv
n
decreas
continu
death
fig
supplementari
tabl
particularli
ldl
level
show
irrevers
decreas
percentag
death
p
versu
level
admiss
fig
supplementari
tabl
supplementari
tabl
show
timelin
diseas
cours
nonsurviv
patient
hospit
admiss
death
continu
irrevers
decreas
ldl
hdl
tc
level
ldl
hdl
tc
level
normal
subject
patient
copd
control
group
show
signific
differ
compar
level
patient
viral
infect
supplementari
tabl
logist
regress
analysi
show
increas
odd
lower
ldl
level
associ
diseas
progress
chisquar
p
odd
ratio
ic
p
inhospit
mortal
chisquar
p
odd
ratio
ic
p
ratio
chang
ldl
hdl
tc
invers
correl
ratio
chang
hscrp
diseas
cours
fig
studi
report
dyslipidemia
patient
demonstr
degre
decreas
ldl
level
high
odd
associ
sever
mortal
diseas
ldl
togeth
risk
factor
older
age
high
sequenti
organ
failur
assess
ddimer
may
aid
physician
identifi
patient
poor
prognosi
earli
phase
sever
possibl
explan
aberr
lipid
level
patient
first
may
result
liver
injuri
although
liver
function
exhibit
mild
abnorm
protein
synthesi
supplementari
tabl
whether
lipid
biogenesi
impair
yet
determin
second
viral
infect
induc
proinflammatori
cytokin
modul
lipid
metabol
includ
oxid
ldl
reactiv
oxygen
speci
singl
facilit
ldl
clearanc
measur
oxid
ldl
patient
serum
aid
determin
mechan
third
patient
may
increas
vascular
permeabl
caus
viralinduc
inflamm
exud
found
evid
earli
phase
lung
patholog
exud
fluid
contain
high
level
protein
cholesterol
caus
inflammationrel
vascular
permeabl
may
one
possibl
mechan
underli
data
major
limit
studi
includ
small
size
patient
lack
inform
specif
lipoprotein
oxid
ldl
anoth
limit
lack
data
set
lipid
monitor
hospit
diseas
group
address
specif
ldl
level
sever
also
posit
dyslipidemia
play
import
role
patholog
develop
mechan
need
urgent
investig
conclus
result
demonstr
ldl
decreas
associ
patholog
cours
serv
factor
access
diseas
progress
mortal
dr
tan
zhang
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
concept
design
fan
wang
tan
zhang
acquisit
analysi
interpret
data
fan
wang
ye
cao
xu
draft
manuscript
tan
statist
analysi
cao
tan
supervis
tan
zhang
none
materi
manuscript
publish
consider
public
elsewher
includ
internet
studi
support
health
commiss
hubei
provinc
grant
jf
author
profession
financi
affili
may
perceiv
bias
present
data
point
ratio
normal
level
ldl
hdl
tc
prior
infect
patient
day
list
durat
median
iqr
period
diseas
cours
date
admiss
set
day
data
present
mean
confid
interv
indic
p
b
compar
level
preinfect
stage
indic
p
b
compar
level
admiss
mannwhitney
u
test
sampl
actual
valu
stage
list
supplementari
tabl
ratio
hscrp
time
point
normal
level
prior
infect
patient
pearson
correl
coeffici
analysi
show
ratio
hscrp
significantli
invers
correl
ratio
ldl
hdl
e
tc
f
diseas
cours
n
data
pair
analysi
